LinkedIn-button

Services

Vaccine
development
service

The bridge between discovery and pilot scale
GMP biomanufacturing

LEARN MORE
LinkedIn-button

Discover
Intravacc

The Netherlands-based Intravacc is one of the world’s leading institutes for translational vaccinology. As an established independent CDMO organization with many years of experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology all over the globe, including oral polio vaccines, measles vaccines, and DPT, Hib and influenza vaccines.

MANAGEMENT
LinkedIn-button

Latest News

Press Release

Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine Bilthoven, the Netherlands, 13 April 2021 – Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced positive preclinical data for its OMV based Lyme…

Intravacc announces positive preclinical data for its OMV-based Lyme vaccine
  • Neisserial OMV based Lyme vaccine elicit high antibody titers in mice
  • Further evidence for Intravacc's versatile multi-disease OMV platform
  • Data are published in peer reviewed journal Vaccine
Read more

Press Release

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine Bilthoven, the Netherlands, 7 April 2021 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has obtained positive pre-clinical results…

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine
  • Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2
  • Intranasal vaccine administration has significant advantages over injectables
  • OMV technology is a powerful vaccine platform for future pandemics
Read more

Press Release

Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer Bilthoven, the Netherlands, 24 March 2021 – Intravacc, a world leader in translational research and development of vaccines, today announced the appointment of Nathalie Laarakker as Chief Financial Officer and member…

Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer
Read more
LinkedIn-button

Career

Join our team!

Are you interested in becoming part of an innovative community, to learn alongside top scientists, to work with state-of-the art equipment, to get an inside look of and contribute to the biotech sector, where industry leaders, government, universities and international non-governmental organizations collaborate? Then Intravacc is the place for you.

YOUR CAREER?

Subscribe to our news update

Stay up to date with the latest developments, and be the first to receive our news updates and announcements.